These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10568522)

  • 21. [Presenilins as a marker of Alzheimer's disease].
    Scheper W; van Gool WA
    Ned Tijdschr Geneeskd; 1998 May; 142(22):1247-52. PubMed ID: 9749296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
    Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
    Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Alzheimer's disease: genetic influences on the disease process (Review).
    Lippa CF
    Int J Mol Med; 1999 Nov; 4(5):529-36. PubMed ID: 10534576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline mutational analysis of presenilin 1 and APP genes in Jewish-Israeli individuals with familial or early-onset Alzheimer disease using denaturing gradient gel electrophoresis (DGGE).
    Reznik-Wolf H; Treves TA; Shabtai H; Aharon-Peretz J; Chapman J; Davidson M; Barkai G; Hyslop PH; Goldman B; Korczyn AD; Friedman E
    Eur J Hum Genet; 1998; 6(2):176-80. PubMed ID: 9781063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of [3H]dopamine release by glutathione in mouse striatal slices.
    Janáky R; Dohovics R; Saransaari P; Oja SS
    Neurochem Res; 2007 Aug; 32(8):1357-64. PubMed ID: 17401648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in glutathione metabolism in Alzheimer's disease.
    Liu H; Harrell LE; Shenvi S; Hagen T; Liu RM
    J Neurosci Res; 2005 Mar; 79(6):861-7. PubMed ID: 15693022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.
    Chan SL; Furukawa K; Mattson MP
    Neuromolecular Med; 2002; 2(2):167-96. PubMed ID: 12428810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of presenilins in cell-survival signalling pathways.
    McCarthy JV
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):568-72. PubMed ID: 16042546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum.
    Walter J; Capell A; Grünberg J; Pesold B; Schindzielorz A; Prior R; Podlisny MB; Fraser P; Hyslop PS; Selkoe DJ; Haass C
    Mol Med; 1996 Nov; 2(6):673-91. PubMed ID: 8972483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.
    Sido B; Hack V; Hochlehnert A; Lipps H; Herfarth C; Dröge W
    Gut; 1998 Apr; 42(4):485-92. PubMed ID: 9616308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease.
    Mohmmad Abdul H; Wenk GL; Gramling M; Hauss-Wegrzyniak B; Butterfield DA
    Neurosci Lett; 2004 Sep; 368(2):148-50. PubMed ID: 15351438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated presenilin-1 endoproteolysis enhances store-operated calcium currents in neuronal cells.
    Ryazantseva M; Skobeleva K; Glushankova L; Kaznacheyeva E
    J Neurochem; 2016 Mar; 136(5):1085-95. PubMed ID: 26678016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical trauma decreases glutathione synthetic capacity in human skeletal muscle tissue.
    Luo JL; Hammarqvist F; Andersson K; Wernerman J
    Am J Physiol; 1998 Aug; 275(2):E359-65. PubMed ID: 9688640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.
    Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ
    Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease.
    Schindowski K; Kratzsch T; Peters J; Steiner B; Leutner S; Touchet N; Maurer K; Czech C; Pradier L; Frölich L; Müller WE; Eckert A
    Neuromolecular Med; 2003; 4(3):161-78. PubMed ID: 14716024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [From gene to disease; presenilins and Alzheimer disease].
    Roos RA; Cruts M
    Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2027-9. PubMed ID: 11695101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients.
    Tanahashi H; Kawakatsu S; Kaneko M; Yamanaka H; Takahashi K; Tabira T
    Neurosci Lett; 1996 Nov; 218(2):139-41. PubMed ID: 8945747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.